Outlining new frontiers for the comprehension of obsessive-compulsive disorder: A review of its relationship with fear and anxiety

Revista Brasileira de Psiquiatria

Volumn 34, Issue SUPP 1, 2012, Pages

  Diniz, Juliana Belo ^a   Miguel, Euripedes Constantino ^a   de Oliveira, Amanda Ribeiro ^a,b   Reimer, Adriano Edgar ^a,b   Brandão, Marcus Lira ^a,b   de Mathis, Maria Alice ^a   Batistuzzo, Marcelo Camargo ^a   Costa, Daniel Lucas Conceição ^a   Hoexter, Marcelo Queiroz ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Neuroscience and Behavior   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety Disorders; Epidemiology; Fear; Neuroimaging; Obsessive Compulsive Disorder; Post Traumatic; Stress Disorders; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; IMIPRAMINE; OXYTOCIN; QUINPIROLE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGORAPHOBIA; AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; ATTENTION; BRAIN CORTEX; BREATHING EXERCISE; COMORBIDITY; COMPULSION; CONDITIONING; CORPUS STRIATUM; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DSM-IV-TR; ELECTROPHYSIOLOGY; FEAR; FUNCTIONAL NEUROIMAGING; GENERALIZED ANXIETY DISORDER; GILLES DE LA TOURETTE SYNDROME; GROOMING; HUMAN; HYPERACTIVITY; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PANIC; PATHOPHYSIOLOGY; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RELAXATION TRAINING; REVIEW; SENSORY GATING; SEPARATION ANXIETY; SEROTONINERGIC SYSTEM; SOCIAL PHOBIA; STEREOTYPY; TREATMENT RESPONSE;

EID: 84863772700     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1516-4446(12)70056-9     Document Type: Review

References (144)

1. Stein D. Psychobiology of anxiety disorders and obsessivecompulsive spectrum disorders. CNS Spectr. 2008;13(9Suppl14): 23-8.
2. Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety. 2008;25(4):317-29.
3. Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, Farrow J, Leckman J. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety. 2010;27(6):528-55.
4. Stein DJ, Craske MG, Friedman MJ, Phillips KA. Meta-structure issues for the DSM-5: how do anxiety disorders, obsessivecompulsive and related disorders, post-traumatic disorders, and dissociative disorders fit together? Curr Psychiatry Rep. 2011;13(4):248-50.
5. Griffin JB. Anxiety. In: Walker HK, Hall, WD, Hurst, JW (editors). Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworth Publishers, a division of Reed Publishing; 1990.
6. Miguel EC, do Rosário-Campos MC, Prado HS, do Valle R, Rauch SL, Coffey BJ, Baer L, Savage CR, O'Sullivan RL, Jenike MA, Leckman JF. Sensory phenomena in obsessivecompulsive disorder and Tourette's disorder. J Clin Psychiatry. 2000;61(2):150-6;quiz7.
7. Prado HS, Rosário MC, Lee J, Hounie AG, Shavitt RG, Miguel EC. Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature. CNS Spectr. 2008;13(5):425-32.
8. Lee JC, Prado HS, Diniz JB, Borcato S, da Silva CB, Hounie AG, Miguel EC, Leckman JF, do Rosário MC. Perfectionism and sensory phenomena: phenotypic components of obsessivecompulsive disorder. Compr Psychiatry. 2009;50(5):431-6.
9. Miguel E, Baer L, Coffey B, Rauch S, Savage C, O'Sullivan R, Phillips K, Moretti C, J Leckman JF, Jenike MA. Phenomenological differences appearing with repetitive behaviours in obsessivecompulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry. 1997;170:140-5.
10. Engelhard IM, Olatunji BO, de Jong PJ. Disgust and the development of posttraumatic stress among soldiers deployed to Afghanistan. J Anxiety Disord. 2011;25(1):58-63.
11. Davey GC. Disgust: the disease-avoidance emotion and its dysfunctions. Philos Trans R Soc Lond B Biol Sci. 2011;366(1583):3453-65.
12. Davey GC, Macdonald BA, Brierley L. The effect of disgust on anxiety ratings to fear-relevant, disgust-relevant and fearirrelevant stimuli. J Anxiety Disord. 2008;22(8):1347-54.
13. Neziroglu F, Henricksen J, Yaryura-Tobias J. Psychotherapy of obsessive-compulsive disorder and spectrum: established facts and advances, 1995-2005. Psychiatr Clin North Am. 2006;29(2):585-604.
14. Pigott TA, L'Heureux F, Dubbert B, Bernstein S, Murphy DL. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry. 1994;55(Suppl):15-27; discussion 8-32.
15. Yaryura-Tobias JA, Grunes MS, Todaro J, McKay D, Neziroglu FA, Stockman R. Nosological insertion of axis I disorders in the etiology of obsessive-compulsive disorder. J Anxiety Disord. 2000;14(1):19-30.
16. Tükel R, Polat A, Ozdemir O, Aksüt D, Türksoy N. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry. 2002;43(3):204-9.
17. Denys D, Tenney N, van Megen HJ, de Geus F, Westenberg HG. Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord. 2004;80(2-3):155-62.
18. Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R, Lewis G, Meltzer H, Singleton N. Obsessivecompulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006;163(11):1978-85.
19. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
20. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry. 1994;55(Suppl):5-10.
21. Douglass HM, Moffitt TE, Dar R, McGee R, Silva P. Obsessivecompulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1424-31.
22. Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, Rasmussen SA. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry. 1999;60(5):346-51;quiz 52.
23. Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, John U. Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci. 2001;251(3):130-5.
24. Austin LS, Lydiard RB, Fossey MD, Zealberg JJ, Laraia MT, Ballenger JC. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1990;51(11):456-8.
25. Brakoulias V, Starcevic V, Sammut P, Berle D, Milicevic D, Moses K, Hannan A. Obsessive-compulsive spectrum disorders: a comorbidity and family history perspective. Australas Psychiatry. 2011;19(2):151-5.
26. LaSalle VH, Cromer KR, Nelson KN, Kazuba D, Justement L, Murphy DL. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessivecompulsive disorder. Depress Anxiety. 2004;19(3):163-73.
27. Rasmussen SA, Eisen JL. Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bull. 1988;24(3):466-70.
28. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15(4):743-58.
29. Masi G, Millepiedi S, Mucci M, Bertini N, Pfanner C, Arcangeli F. Comorbidity of obsessive-compulsive disorder and attentiondeficit/ hyperactivity disorder in referred children and adolescents. Compr Psychiatry. 2006;47(1):42-7.
30. Crino RC, Andrews G. Obsessive-compulsive disorder and axis I comorbidity. Journal of Anxiety Disorders; 1996. pp. 37-46.
31. Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986;143(3):317-22.
32. Eilam D, Zor R, Szechtman H, Hermesh H. Rituals, stereotypy and compulsive behavior in animals and humans. Neurosci Biobehav Rev. 2006;30(4):456-71.
33. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):374-88.
34. Korff S, Harvey BH. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Psychiatr Clin North Am. 2006;29(2):371-90.
35. Stein DJ, Dodman NH, Borchelt P, Hollander E. Behavioral disorders in veterinary practice: relevance to psychiatry. Compr Psychiatry. 1994;35(4):275-85.
36. Veith L. Acral lick dermatitis in the dog. Canine Practice. 1986(13):15-22.
37. Garner JP, Weisker SM, Dufour B, Mench JA. Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comp Med. 2004;54(2):216-24.
38. Sarna JR, Dyck RH, Whishaw IQ. The Dalila effect: C57BL6 mice barber whiskers by plucking. Behav Brain Res. 2000;108(1):39-45.
39. Einat H, Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiol Behav. 1995;57(1):55-9.
40. Yadin E, Friedman E, Bridger WH. Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder? Pharmacol Biochem Behav. 1991;40(2):311-5.
41. Szechtman H, Sulis W, Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav Neurosci. 1998;112(6):1475-85.
42. Henderson JG, Pollard CA. Three types of obsessive compulsive disorder in a community sample. J Clin Psychol. 1988;44(5):747-52.
43. Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 1994;55(Suppl):5-10;discussion 1-4.
44. Szechtman H, Eckert MJ, Tse WS, Boersma JT, Bonura CA, McClelland JZ, Culver KE, Eilam D. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control. BMC Neurosci. 2001;2:4.
45. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC, Cohen DJ. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology. 1994;19(8):723-49.
46. Leckman J, Goodman W, North W, Chappell P, Price L, Pauls D, derson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994;51(10):782-92.
47. Marroni SS, Nakano FN, Gati CD, Oliveira JA, Antunes-Rodrigues J, Garcia-Cairasco N. Neuroanatomical and cellular substrates of hypergrooming induced by microinjection of oxytocin in central nucleus of amygdala, an experimental model of compulsive behavior. Mol Psychiatry. 2007;12(12):1103-17.
48. Sachs BD. The development of grooming and its expression in adult animals. Ann N Y Acad Sci. 1988;525:1-17.
49. Spruijt BM, van Hooff JA, Gispen WH. Ethology and neurobiology of grooming behavior. Physiol Rev. 1992;72(3):825-52.
50. Altemus M, Glowa JR, Galliven E, Leong YM, Murphy DL. Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav. 1996;53(1):123-31.
51. Altemus M, Glowa JR, Murphy DL. Attenuation of foodrestriction-induced running by chronic fluoxetine treatment. Psychopharmacol Bull. 1993;29(3):397-400.
52. Falk JR, Halmi KA, Tryon WW. Activity measures in anorexia nervosa. Arch Gen Psychiatry. 1985;42(8):811-4.
53. Kron L, Katz JL, Gorzynski G, Weiner H. Hyperactivity in anorexia nervosa: a fundamental clinical feature. Compr Psychiatry. 1978;19(5):433-40.
54. Joel D, Avisar A. Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder? Behav Brain Res. 2001;123(1):77-87.
55. Joel D, Ben-Amir E, Doljansky J, Flaisher S. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. Behav Pharmacol. 2004;15(3):241-52.
56. Joel D, Doljansky J. Selective alleviation of compulsive leverpressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder. Neuropsychopharmacology. 2003;28(1):77-85.
57. Broekkamp CL, Rijk HW, Joly-Gelouin D, Lloyd KL. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur J Pharmacol. 1986;126(3):223-9.
58. Londei T, Valentini AM, Leone VG. Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res. 1998;94(2):249-54.
59. Njung'e K, Handley SL. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol. 1991;104(1):105-12.
60. Treit D, Pinel JP, Fibiger HC. Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav. 1981;15(4):619-26.
61. Hoexter MQ, de Souza Duran FL, D'Alcante CC, Dougherty DD, Shavitt RG, Lopes AC, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto RGF. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Neuropsychopharmacology. 2012;37(3):734-45.
62. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23(3):563-86.
63. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43-51.
64. Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169-91.
65. Lehman JF, Greenberg BD, McIntyre CC, Rasmussen SA, Haber SN. Rules ventral prefrontal cortical axons use to reach their targets: implications for diffusion tensor imaging tractography and deep brain stimulation for psychiatric illness. J Neurosci. 2011;31(28):10392-402.
66. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessivecompulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525-49.
67. Ongür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10(3):206-19.
68. Milad MR, Rauch SL, Pitman RK, Quirk GJ. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol. 2006;73(1):61-71.
69. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry. 2007;62(5):446-54.
70. Rauch SL, Dougherty DD, Malone D, Rezai A, Friehs G, Fischman AJ, Alpert NM, Haber SN, Stypulkowski PH, Rise MT, Rasmussen SA, Greenberg BD. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg. 2006;104(4):558-65.
71. Hughes KC, Shin LM. Functional neuroimaging studies of post-traumatic stress disorder. Expert Rev Neurother. 2011;11(2):275-85.
72. de Carvalho MR, Dias GP, Cosci F, de-Melo-Neto VL, Bevilaqua MC, Gardino PF, Nardi AE. Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Rev Neurother. 2010;10(2):291-303.
73. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476-88.
74. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry. 2010;167(5):545-54.
75. Simon D, Kaufmann C, Müsch K, Kischkel E, Kathmann N. Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. Psychophysiology. 2010;47(4):728-38.
76. Cardoner N, Harrison BJ, Pujol J, Soriano-Mas C, Hernández-Ribas R, López-Solá M, Real E, Deus J, Ortiz H, Alonso P, Menchónr JM. Enhanced brain responsiveness during active emotional face processing in obsessive compulsive disorder. World J Biol Psychiatry. 2011;12(5):349-63.
77. Cannistraro PA, Wright CI, Wedig MM, Martis B, Shin LM, Wilhelm S, Rauch SL. Amygdala responses to human faces in obsessivecompulsive disorder. Biol Psychiatry. 2004;56(12):916-20.
78. Hofmann SG. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clin Psychol Rev. 2008;28(2):199-210.
79. Foa EB, Zinbarg R, Rothbaum BO. Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model. Psychol Bull. 1992;112(2):218-38.
80. McTeague LM, Lang PJ, Laplante MC, Bradley MM. Aversive imagery in panic disorder: agoraphobia severity, comorbidity, and defensive physiology. Biol Psychiatry. 2011;70(5):415-24.
81. Holstein DH, Vollenweider FX, Jäncke L, Schopper C, Csomor PA. P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. J Affect Disord. 2010;126(1-2):188-97.
82. Cornwell BR, Heller R, Biggs A, Pine DS, Grillon C. Becoming the center of attention in social anxiety disorder: startle reactivity to a virtual audience during speech anticipation. J Clin Psychiatry. 2011;72(7):942-8.
83. Ray WJ, Molnar C, Aikins D, Yamasaki A, Newman MG, Castonguay L, Borkovec TD. Startle response in generalized anxiety disorder. Depress Anxiety. 2009;26(2):147-54.
84. Buhlmann U, Wilhelm S, Deckersbach T, Rauch SL, Pitman RK, Orr SP. Physiologic responses to loud tones in individuals with obsessive-compulsive disorder. Psychosom Med. 2007;69(2):166-72.
85. Kumari V, Kaviani H, Raven PW, Gray JA, Checkley SA. Enhanced startle reactions to acoustic stimuli in patients with obsessivecompulsive disorder. Am J Psychiatry. 2001;158(1):134-6.
86. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci. 2001;24:897-931.
87. Fredrikson M, Annas P, Georgiades A, Hursti T, Tersman Z. Internal consistency and temporal stability of classically conditioned skin conductance responses. Biol Psychol. 1993;35(2):153-63.
88. Bankart CP, Elliott R. Heart rate and skin conductance in anticipation of shocks with varying probability of occurrence. Psychophysiology. 1974;11(2):160-74.
89. Merckelbach H, de Ruiter C, van den Hout MA, Hoekstra R. Conditioning experiences and phobias. Behav Res Ther. 1989;27(6):657-62.
90. Haddad AD, Lissek S, Pine DS, Lau JY. How do social fears in adolescence develop? Fear conditioning shapes attention orienting to social threat cues. Cogn Emot. 2011;25(6):1139-47.
91. Lissek S, Levenson J, Biggs AL, Johnson LL, Ameli R, Pine DS, Grillon C. Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. Am J Psychiatry. 2008;165(1):124-32.
92. Michael T, Blechert J, Vriends N, Margraf J, Wilhelm FH. Fear conditioning in panic disorder: Enhanced resistance to extinction. J Abnorm Psychol. 2007;116(3):612-7.
93. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res. 2008;42(7):515-20.
94. Orr SP, Metzger LJ, Pitman RK. Psychophysiology of post-traumatic stress disorder. Psychiatr Clin North Am. 2002;25(2):271-93.
95. Nanbu M, Kurayama T, Nakazawa K, Matsuzawa D, Komiya Z, Haraguchi T, Ogura H, Hashimoto T, Yoshida S, Iyo M, Shimizu E. Impaired P50 suppression in fear extinction in obsessivecompulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):317-22.
96. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001;156(2-3):234-58.
97. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety. 2002;15(2):55-60.
98. Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry Neurosci. 2005;30(1):37-43.
99. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS. Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res. 1996;64(3):169-78.
100. Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M. Impaired prepulse inhibition of acoustic startle in obsessivecompulsive disorder. Biol Psychiatry. 2005;57(10):1153-8.
101. Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Impaired Sensorimotor gating in unmedicated adults with obsessivecompulsive disorder. Neuropsychopharmacology. 2012 [Epub ahead of print].
102. Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry. 2001;50(8):578-85.
103. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry. 1996;39(1):33-41.
104. Lipschitz DS, Mayes LM, Rasmusson AM, Anyan W, Billingslea E, Gueorguieva R, Southwick SM. Baseline and modulated acoustic startle responses in adolescent girls with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(8):807-14.
105. Schall U, Schön A, Zerbin D, Eggers C, Oades RD. Eventrelated potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. Int J Neurosci. 1996;84(1-4):15-33.
106. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001;156(2-3):117-54.
107. Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol. 2000;11(3-4):185-204.
108. Chamberlain S, Blackwell A, Fineberg N, Robbins T, Sahakian B. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005;29(3):399-419.
109. Grisham JR, Anderson TM, Poulton R, Moffitt TE, Andrews G. Childhood neuropsychological deficits associated with adult obsessive-compulsive disorder. Br J Psychiatry. 2009;195(2):138-41.
110. Chamberlain SR, Menzies L. Endophenotypes of obsessivecompulsive disorder: rationale, evidence and future potential. Expert Rev Neurother. 2009;9(8):1133-46.
111. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry. 1998;55(5):415-23.
112. Clayton IC, Richards JC, Edwards CJ. Selective attention in obsessive-compulsive disorder. J Abnorm Psychol. 1999;108(1):171-5.
113. Boldrini M, Del Pace L, Placidi GP, Keilp J, Ellis SP, Signori S, Placidi GF, Cappa SF. Selective cognitive deficits in obsessivecompulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr Scand. 2005;111(2):150-8.
114. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM. Executive functions in obsessive-compulsive disorder: state or trait deficits? Aust N Z J Psychiatry. 2006;40(11-12):1031-8.
115. Cisler JM, Olatunji BO. Components of attentional biases in contamination fear: evidence for difficulty in disengagement. Behav Res Ther. 2010;48(1):74-8.
116. Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van IJzendoorn MH. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull. 2007;133(1):1-24.
117. Kwak SM, Na DL, Kim G, Kim GS, Lee JH. Use of eye movement to measure smokers' attentional bias to smoking-related cues. Cyberpsychol Behav. 2007;10(2):299-304.
118. Rinck M, Becker ES. Spider fearful individuals attend to threat, then quickly avoid it: evidence from eye movements. J Abnorm Psychol. 2006;115(2):231-8.
119. Lavy E, van den Hout M, Arntz A. Attentional bias and spider phobia: conceptual and clinical issues. Behav Res Ther. 1993;31(1):17-24.
120. Amir N, Elias J, Klumpp H, Przeworski A. Attentional bias to threat in social phobia: facilitated processing of threat or difficulty disengaging attention from threat? Behav Res Ther. 2003;41(11):1325-35.
121. Spector IP, Pecknold JC, Libman E. Selective attentional bias related to the noticeability aspect of anxiety symptoms in generalized social phobia. J Anxiety Disord. 2003;17(5):517-31.
122. Bradley BP, Mogg K, White J, Groom C, de Bono J. Attentional bias for emotional faces in generalized anxiety disorder. Br J Clin Psychol. 1999;38 (Pt 3):267-78.
123. Fleurkens P, Rinck M, van Minnen A. Specificity and generalization of attentional bias in sexual trauma victims suffering from posttraumatic stress disorder. J Anxiety Disord. 2011;25(6):783-7.
124. Reinecke A, Cooper M, Favaron E, Massey-Chase R, Harmer C. Attentional bias in untreated panic disorder. Psychiatry Res. 2011;185(3):387-93.
125. Tata PR, Leibowitz JA, Prunty MJ, Cameron M, Pickering AD. Attentional bias in obsessional compulsive disorder. Behav Res Ther. 1996;34(1):53-60.
126. Moritz S, von Mühlenen A. Investigation of an attentional bias for fear-related material in obsessive-compulsive checkers. Depress Anxiety. 2008;25(3):225-9.
127. Harkness EL, Harris LM, Jones MK, Vaccaro L. No evidence of attentional bias in obsessive compulsive checking on the dot probe paradigm. Behav Res Ther. 2009;47(5):437-43.
128. Sizino da Victoria M, Nascimento AL, Fontenelle LF. Symptom-specific attentional bias to threatening stimuli in obsessive-compulsive disorder. Compr Psychiatry. 2012; [Epub ahead of print].
129. Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry. 2010;71(7):839-54.
130. Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S, et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl. 1991;365:18-27.
131. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. J Clin Psychopharmacol. 1990;10(2):112-8.
132. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder. A placebocontrolled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry. 1993;50(11):884-95.
133. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, Saunders WB, Cavenar JO Jr. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47(3):259-66.
134. Fineberg N, Bullock T, Montgomery D, Montgomery S. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder. Int Clin Psychopharmacol. 1992;7(Suppl1):43-7.
135. Lowry CA, Hale MW, Evans AK, Heerkens J, Staub DR, Gasser PJ, Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci. 2008;1148:86-94.
136. Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress. 2005;8(4):233-46.
137. Bespalov AY, van Gaalen MM, Gross G. Antidepressant treatment in anxiety disorders. Curr Top Behav Neurosci. 2010;2:361-90.
138. Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30(6):635-41.
139. Pachana NA, Woodward RM, Byrne GJ. Treatment of specific phobia in older adults. Clin Interv Aging. 2007;2(3):469-76.
140. Singh JS, Hope DA. Cognitive-behavioral approaches to the treatment of social anxiety disorder. Isr J Psychiatry Relat Sci. 2009;46(1):62-9.
141. Ham P, Waters DB, Oliver MN. Treatment of panic disorder. Am Fam Physician. 2005;71(4):733-9.
142. Belotto-Silva C, Diniz JB, Malavazzi DM, Valério C, Fossaluza V, Borcato S, Seixas AA, Morelli D, Miguel EC, Shavitt RG. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial. J Anxiety Disord. 2012;26(1):25-31.
143. Kaplan GB, Heinrichs SC, Carey RJ. Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacol Biochem Behav. 2011;97(3):619-25.
144. Storch E, Mariaskin A, Murphy T. Psychotherapy for obsessivecompulsive disorder. Curr Psychiatry Rep. 2009;11(4):296-301.